A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety
- PMID: 15514229
- PMCID: PMC1448561
- DOI: 10.2105/ajph.94.11.1926
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety
Abstract
Established in 1999, the Global Advisory Committee on Vaccine Safety advises the World Health Organization (WHO) on vaccine-related safety issues and enables WHO to respond promptly, efficiently, and with scientific rigor to issues of vaccine safety with potential global importance. The committee also assesses the implications of vaccine safety for practice worldwide and for WHO policies. We describe the principles on which the committee was established, its modus operandi, and the scope of the work undertaken, both present and future. We highlight its recent recommendations on major issues, including the purported link between the measles-mumps-rubella vaccine and autism and the safety of the mumps, influenza, yellow fever, BCG, and smallpox vaccines as well as that of thiomersal-containing vaccines.
References
-
- Biellik R, Madema S, Taole A, Kutsulukuta A, Allies E, Eggers R, et al. First 5 years of measles elimination in southern Africa: 1996–2000. Lancet. 2002;359:1564–1568. - PubMed
-
- Isaacs SL, Schroeder SA. Where the public good prevailed: lessons from success stories in public health. Am Prospect. 2001;12:26.
-
- State of the World’s Vaccines and Immunization. Geneva, Switzerland: World Health Organization; 2002.
-
- Vaccine Safety Advisory Committee. Vaccine safety. Wkly Epidemiol Rec. 1999;74:337–340. - PubMed
-
- Causality assessment of adverse events following immunization. Wkly Epidemiol Rec. 2001;76:85–92. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
